Liberate Medical Revenue and Competitors
Employee Data
- Liberate Medical has 15 Employees.
- Liberate Medical grew their employee count by 88% last year.
Liberate Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder / CEO | Reveal Email/Phone |
2 | VP Engineering | Reveal Email/Phone |
3 | Director, Engineering Research | Reveal Email/Phone |
4 | Electrical Engineer | Reveal Email/Phone |
5 | Biomedical Engineering Co-op | Reveal Email/Phone |
Liberate Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 27 | 93% | N/A | N/A |
#2 | N/A | 15 | 88% | N/A | N/A |
#3 | $1.7M | 6 | -14% | N/A | N/A |
#4 | $3.5M | 92 | 10% | N/A | N/A |
What Is Liberate Medical?
Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology to improve the quality and reduce the cost of care for patients with pulmonary disorders.Liberate's lead product, the VentFree™ respiratory muscle stimulator. Invasive mechanical ventilation commonly weakens the breathing muscles, increasing the need for further ventilator support.VentFree applies proprietary, non-invasive, electrical stimulation to the expiratory muscles in synchrony with exhalation while a patient is on mechanical ventilation. This breakthrough therapy, which is quick and simple to use, is intended to reduce abdominal muscle atrophy and the time taken to liberate patients from mechanical ventilation.Reduced days on mechanical ventilation can potentially lead to reduced morbidity and mortality, improved quality of life, and considerable savings for the health care provider.
keywords:N/AN/A
Total Funding
15
Number of Employees
N/A
Revenue (est)
88%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.2M | 28 | 4% | N/A |
#2 | $5.3M | 28 | -7% | N/A |
#3 | $7.2M | 31 | 0% | N/A |
#4 | $4.8M | 33 | 10% | N/A |
#5 | $35M | 36 | 6% | N/A |